Formulation of Conjugated Linoleic Acid Microemulsion Using Mixed Nonionic Surfactants

A novel class of conjugated linoleic acid (CLA)-in-water microemulsion based on Tween80, EL-35, ethanol, and n-octanol was investigated as potential food delivery systems. The influences of pH on the microemulsion region were considered. The microemulsion structural transition was divided into water-in-oil (W/O), bicontionuous, and oil-in-water (O/W) microemulsion by conductivity and viscosity method. The microemulsion size and polydispersity were determined by dynamic light scattering (DLS). The size of O/W microemulsion droplets depends strongly on the contents of surfactants and CLA, and the diameter ranges from 22.1 to 30.7 nm and from 18.3 to 32.8 nm, respectively. All samples keep a remarkable stability in the experiments of 30 days. The stability of CLA in microemulsion and ethanol solution was determined by ultraviolet-visible spectrophotometry, the results revealed that the stability of the CLA in the microemulsion was increased remarkably.     

有机硅-丙烯酸酯微乳液的合成与表征

采用高温乳化种子单体滴加法制备了有机硅-丙烯酸酯共聚微乳液。对合成条件及微乳液的性能进行了研究。用红外光谱(FT-IR)、透射电镜(TEM)、动态激光粒度仪(PCS)对微乳液的结构和粒子形态进行了表征。结果表明:有机硅氧烷与丙烯酸酯发生了共聚反应,生成的微乳液粒子大致为球形结构,粒子大小比较均一,粒径较小。     

纳米钴蓝颜料的微乳法制备及其表征

纳米粒子;微乳液;量子尺寸效应;纳米钴蓝颜料的微乳法制备及其表征     

毛细管电泳法测定复方制剂中的硝酸咪康唑

毛细管电泳;高频电导检测;非接触式电导检测;硝酸咪康唑;复方制剂     

一维CuO纳米棒的微乳-均匀沉淀耦合法制备与结构表征

以CuSO4和NH3·H2O为原料,采用微乳-均匀沉淀耦合法制备了一维CuO纳米棒。用XRD、SEM、TEM、HRTEM和FTIR对产物的结构和形貌进行了表征。结果表明:产物为单斜晶相结构的CuO纳米棒,内部具有孔洞结构,其直径为40～110nm,长度为800～3000nm。可通过改变水核比(ω)、反应物的浓度、反应时间、反应温度等条件实现对CuO纳米棒形貌和尺寸的调控。探讨了可能的反应机理,并用热分析方法考察了CuO纳米棒对高氯酸铵(AP)分解的催化作用。     

Design and Development of Oral Oil-in-Water Nanoemulsion Formulation Bearing Atorvastatin: In Vitro Assessment

The objective of the present investigation was to design a thermodynamically stable and dilutable nanoemulsion formulation of AT-Ca with minimum surfactant concentration that could improve its solubility as well as its oral bioavailability. The composition of optimized nanoemulsion formulation was Sefsol 218 and oleic acid (1:1) 10% w/w, as an oil phase, Tween-20 (19% w/w) as a surfactant, Carbitol (19% w/w) as a cosurfactant and distilled water (52% w/w) as an aqueous phase, containing 10 mg of AT. The optimized formulation showed higher% drug release (99.34%), lower droplet size (42.8 ± 0.42 nm) with low polydispersity index (0.237 ± 0.012), less viscosity (27.51 ± 1.01 cP) and infinite dilution capability. In vitro drug release from the nanoemulsion formulations was highly significant (p < 0.01) as compared to drug suspension.     

Synthesis and Characterization of Hydrogel Nanoparticles Through Inverse Microemulsion Polymerization of 2-Acrylamido-2-methyl-1-propanesulfonic Acid

Nanosized hydrogel particles prepared through inverse microemulsion polymerization of 2-acrylamido-2-methyl-1-propanesulfonic acid, using the combination of an oil soluble emulsifier (SPAN80) with a water soluble emulsifier (TWEEN 80), and precise determination of HLB range related to the formation of stable single phase microemulsions.

The effect of crosslink density, water phase to oil phase ratio, and the hydrophilic-lipophilic balance (HLB) value on polymerization rate, particle size, and swelling ratio were investigated. It found that polymerization rate and particle size are strongly dependent on the water phase to oil phase ratio. Hydrogel samples prepared using oil soluble and water soluble initiators and the results showed that the initiator type had a great influence on monomer conversion and particle size. Effect of pH on equilibrium swelling of hydrogels was studied by dynamic light scattering and hydrogels showed pH-independent swelling behavior in a broad range of pH values. We also reported and discussed the crosslink density distribution in nanogels prepared by inverse microemulsion polymerization.     

CTAB反相微乳液的稳定条件与纳米WO3的制备

以CTAB(十六烷基三甲基溴化铵)/正丁醇/正辛烷/钨酸钠水溶液构制反相微乳体系,通过测定体系电导率的方法确定相点并绘制反相微乳区拟三元相图。考察了该体系在不同条件下稳定存在的组成范围,选取实验最佳条件制备出纳米WO3。结果表明,表面活性剂与助表面活性剂的比、钨酸钠溶液的浓度对该反相微乳体系稳定区域的影响较大,当m(CTAB)∶m(正丁醇)=1∶2,钨酸钠浓度为0.05～0.08 g/mL时,体系有较大的反向微乳区,且当m(CTAB 正丁醇)∶m(正辛烷)=2∶3时,体系有最大溶水量;温度对该体系稳定区域的影响不大。在最适宜条件下,以0.08 g/mL的钨酸钠微乳液与盐酸微乳液,在40℃的水浴中反应7 h,制备出平均粒径约30 nm的WO3纳米粒子。     

微乳中纳米胶囊的复凝聚法制备

在O/W型APG微乳液模板上, 以明胶和阿拉伯树胶作为包裹材料, 用复凝聚的方法制备纳米胶囊, 对影响纳米胶囊的合成条件进行了分析. 用粒度仪测定产物的粒径及其分布, 用透射电镜观察产物的形貌. 结果表明, 用复凝聚法在微乳中合成了粒度均匀、粒径30～100 nm的球性纳米胶囊. 考察了微乳液的组成、高分子的浓度和复凝聚的条件对纳米胶囊性质的影响. 纳米胶囊对氯氰菊酯的包裹率较高, 在60%以上. 本方法条件温和, 操作简单, 是一种新型的纳米胶囊合成技术.     

油包水型微乳中层柱状磷酸锆的制备与表征

以氧氯化锆(ZrOCl2·8H2O)和磷酸三丁酯(C4H9O)3PO为原料, 在正庚烷(C7H10)-十六烷基三甲基溴化铵(CTAB)/正丁醇(C4H9OH)-水的反向微乳体系中制备了Zr(HPO4)2·H2O, (H3O)+Zr2(PO4)3和Zr(HPO4)8·H2O三种不同结构的层柱状磷酸锆. 运用扫描电子显微镜(SEM)、透射电子显微镜(TEM)和X射线衍射仪(XRD)等仪器对产物进行了表征, 考察了不同微乳组成对磷酸锆结构及尺寸的影响. 结果表明, 微乳体系对层柱状磷酸锆的可控制合成具有广泛意义.     

Co-Fe普鲁士蓝类配合物纳米颗粒的微乳液法制备与表征

Highly oriented cubic, hollow cubic and spherical nanoparticles of cobalt-iron Prussian blue analogues were synthesized in poly oxyethylene tertoctylphenyl ether (TritonX-100)/n-hexanol/cyclohexane microemulsion. The effects of the water-to-surfactant molar ratio (w), the reactant concentration and the reaction temperature on the morphology of cobalt-iron Prussian blue analogues were studied. The samples were characterized by transmission electron microscopy (TEM), field emission scan electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDS), X-ray diffraction (XRD) and infrared spectroscopy (IR).     

Electron Capture Gas Chromatographic Assay for Miconazole and Clotrimazole In Skin Samples

Abstract

Electron capture gas chromatographic assay procedures were developed for quantitating the antifungal agents clotrimazole and miconazole. The procedures were specifically developed for analysis of the drugs in superficial samples of human skin. The analytical methods were sensitive to 5 ng of miconazole and 10 ng clotrimazole per tissue sample.     

Submicron Size Formulation of Linseed Oil Containing Omega-3 Fatty Acid for Topical Delivery

The aim of the present study was to design and develop topical submicron size gel formulation of linseed oil with enhanced permeation through the skin for the management of psoriasis. Linseed oil contains significant amount of α-linolenic acid (ALA) an omega-3 fatty acid, which is responsible for its pharmacological actions. In order to enhance permeation through skin, microemulsion based gel formulation was prepared and characterized. Microemulsions were prepared by aqueous phase titration method, using linseed oil, Unitop 100, PEG 400, and distilled water as the oil phase, surfactant, cosurfactant and aqueous phase, respectively. Selected formulations were subjected to physical stability studies and consequently in vitro skin permeation studies. Surface morphology studies of optimized formulation were done by transmission electron microscopy (TEM). The droplet size of microemulsions ranged from 70 to 500 nm with average particle size 186 nm. The optimized microemulsion was converted into hydrogel using carbopol 971 which had a viscosity of 498 ± 0.04 cps. During in vitro permeation study the flux of microemulsion formulation and gel was found to be 19.05 and 10.2 µg/cm²/hr, respectively, which indicated better penetration of linseed oil through the skin. These result indicated that the developed ME formulation may be a good approach for topical therapy for the management of psoriasis.     

反相微乳法合成稀土六铝酸盐催化剂及其表征

反相微乳法合成稀土六铝酸盐催化剂及其表征;反相微乳法;甲烷;六铝酸盐;过渡金属;稀土     

Formulation and Characterization of Nicotine Microemulsion-Loaded Fast-Dissolving Films for Smoking Cessation

The present study aimed to develop a nicotine microemulsion (NCT-ME) and incorporate it into a fast-dissolving film. The NCT-ME was prepared by mixing the specified proportions of nicotine (NCT), surfactant, co-solvent, and water. The NCT-ME was measured by its average droplet size, size distribution, zeta potential, and morphology. NCT-ME fast-dissolving films were prepared by the solvent casting technique. The films were characterized by morphology, weight, thickness, disintegration time, and mechanical strength properties and the determined NCT loading efficiency and in vitro drug release. The results showed that almost all NCT-MEs presented droplet sizes of less than 100 nm with a spherical form, narrow size distribution, and zeta potentials of −10.6 to −73.7 mV. There was no difference in weight and thickness between all NCT-ME films, but significant changes in the disintegration times were noticed in NCT40-Smix[PEG-40H(2:1)]10 film. The mechanical properties of films varied with changes in type of surfactant. About 80% of the drug release was observed to be between 3 and 30 min. The drug release kinetics were fitted with the Higuchi matrix model. The NCT40-Smix[P-80(1:1)]10 film showed the highest dissolution rate. It was concluded that the developed ME-loaded fast-dissolving film can increase drug release to a greater extent than the films without ME.     

Nonionic Microemulsion: Mechanism of Formation and Percolation

A series of microemulsions, both W/O and O/W, based on nonionic surfactants of the form (NP(EO)_n), were prepared using the titration method. Mixing a constant weight of surfactant with a constant volume of the dispersed phase and an initial volume of continuous phase produces an emulsion, which is titrated to clarity with another surfactant (cosurfactant). Plotting (a) the volume of cosurfactant necessary to transform an emulsion into a microemulsion containing a fixed volume of dispersed phase and constant weight of surfactant versus (b) different initial continuous-phase volumes yields a straight line. Extrapolating from experimentally determined values for the cosurfactant volume to the value corresponding to a zero-volume continuous phase allows the determination of the surfactant molar composition and the average number of ethylene oxides (EO) per nonylphenol adsorbed at the interface. Using a surfactant with the same number of ethylene oxides yields a single-surfactant microemulsion. Measurement of surfactants transmittance in the oil and water phases demonstrates that microemulsification occurs when the surfactant interfacial film is equally soluble in the two phases. Surface pressure measurements reveal that oil penetration impedes formation of O/W microemulsions with n-tetradecane or n-hexadecane as dispersed phase. Conductance, particle size, and transmittance measurements show that above a certain dispersed-phase volume percolation of the microemulsion occurs.     

聚苯醚离聚体水基微乳液粒径及稳定性的研究

以乙酰磺酸为磺为磺化剂制备了磺化度为３～１７ｍｏｌ％的磺化聚苯醚（ＳＰＰＯ）,并中和成盐,在一定的温度和搅拌速度下,加水将ＳＰＰＯ离聚体溶液乳化成水包同的稳定水基微乳液。用光散射法及航向电镜法（ＴＥＭ）测定了ＳＰＰＯ离聚体水基微乳液的粒径及粒径分布,研究了磺化度、溶剂的极性、因含量等因素对微乳液粒径及稳定性的影响。     

Alternative Diesel Fuel: Microemulsion Phase Behavior and Combustion Properties

The phase behavior of water, diesel, limonene, and ethanol was investigated at ambient temperature using single nonionic alkyl polyglycol ethers (C₁₄E₃). Visual inspection as well as crosspolarizers was used to detect transparency and anisotropy. Ternary phase diagrams were determined. Combustion experiments using a four-cylinder diesel engine were carried out. Isotropic water in diesel microemulsion region (L₂) and anisotropic liquid crystalline region (LC) were found with all combinations. Increasing the ratio of limonene to diesel reduced the microemulsion region while the presence of ethanol increased it on the expense of the LC region. Combustion tests performed on a selected formulation from the ternary phase diagram of water, diesel, ethanol, and C₁₄E₃ revealed substantial reduction of soot, NO_x, and CO₂ emissions compared to neat diesel.     

粒径可控阳离子型聚苯乙烯纳米粒子的制备及表征

在采用阳离子型双子（gemini）表面活性剂作为乳化剂,不使用任何助乳化剂的条件下,通过改进微乳液聚合工艺制备了窄分布粒径可控的阳离子型聚苯乙烯（PS）纳米乳液。 改进微乳液聚合的主要特点是：大部分苯乙烯以预乳液的形式恒速滴入引发聚合的微乳液中,使用具有高乳化性能的gemini表面活性剂作为乳化剂能明显降低乳胶粒粒径。 实验结果表明,少量阳离子单体三甲基烯丙基氯化铵作为共聚单体能够明显减小Z均粒径、降低粒度分布,乳化剂用量、引发剂用量和反应温度均能影响制备乳胶粒的粒径及其粒度分布。 乳化剂和引发剂用量分别为苯乙烯质量的5%~10%和1.0%~1.5%、反应温度为70~75 ℃时,能够制备粒径小分布窄的阳离子型聚苯乙烯纳米粒子。 Z均粒径与苯乙烯质量之间的线性关系表明,Z均粒径可以通过苯乙烯用量来控制。 不同聚合工艺下制备的聚合物粒度分布曲线表明,改进微乳液聚合工艺（半连续预乳化工艺）在制备窄分布的聚合物纳米粒子方面具有很强的优越性。     

Thymoquinone Loaded Topical Nanoemulgel for Wound Healing: Formulation Design and In-Vivo Evaluation

Thymoquinone is a natural bioactive with significant therapeutic activity against multiple ailments including wound healing. The poor aqueous solubility and low skin permeability limit its therapeutic efficacy. The present investigation aimed to improve the biopharmaceutical attributes of thymoquinone to enhance its topical efficacy in wound healing. A nanoemulsion-based hydrogel system was designed and characterized as a nanotechnology-mediated drug delivery approach to improve the therapeutic efficacy of thymoquinone, utilizing a high-energy emulsification technique. The black seed oil, as a natural home of thymoquinone, was utilized to improve the drug loading capacity of the developed nanoemulsion system and reduced the oil droplet size to <100 nm through ultrasonication. The influence of formulation composition, and the ultrasonication process conditions, were investigated on the mean globule size and polydispersity index of the generated nanoemulsion. Irrespective of surfactant/co-surfactant ratio and % concentration of surfactant/co-surfactant mixture, the ultrasonication time had a significant (p < 0.05) influence on the mean droplet size and polydispersity index of the generated nanoemulsion. The developed nanoemulgel system of thymoquinone demonstrated the pseudoplastic behavior with thixotropic properties, and this behavior is desirable for topical application. The nanoemulgel system of thymoquinone exhibited significant enhancement (p < 0.05) in skin penetrability and deposition characteristics after topical administration compared to the conventional hydrogel system. The developed nanoemulgel system of thymoquinone exhibited quicker and early healing in wounded Wistar rats compared to the conventional hydrogel of thymoquinone, while showing comparable healing efficacy with respect to marketed silver sulfadiazine (1%) cream. Furthermore, histopathology analysis of animals treated with a developed formulation system demonstrated the formation of the thick epidermal layer, papillary dermis along with the presence of extensive and organized collagen fibers in newly healed tissues. The outcome of this investigation signifies that topical delivery of thymoquinone through nanoemulgel system is a promising candidate which accelerates the process of wound healing in preclinical study.